Advanced search
Publication Cover
Cutaneous and Ocular Toxicology Volume 43, 2024 - Issue 2
Submit an article Journal homepage
34
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Evaluation of corneal endothelial cell morphology off and on treatment by specular microscopy in children and adolescents with attention deficit hyperactivity disorder

Hakan Koca Department of Ophthalmology, Giresun University, Giresun, TurkeyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-1241-1686View further author information
ORCID Icon,
Bedia Sultan Önalb Department of Child and Adolescent Psychiatry, Giresun University, Giresun, TurkeyView further author information
&
Esra Hoşoğluc Department of Child and Adolescent Psychiatry, Karadeniz Technical University, Trabzon, TurkeyView further author information
Pages 120-123 | Received 24 Oct 2023, Accepted 01 Jan 2024, Published online: 18 Jan 2024

References

  • American Psychiatric Association. Diagnostic and statistical manual of mental health disorders. (5th ed.). Arlington, VA: APA; 2019.
  • Thomas R, Sanders S, Doust J, et al. Prevalence of attention-deficit/hyperactivity disorder: a systematic review and meta-analysis. Pediatrics. 2015;135(4):e994–e1001. doi: 10.1542/peds.2014-3482.
  • Goldman LS, Genel M, Bezman RJ, et al. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. JAMA. 1998;279(14):1100–1107. doi: 10.1001/jama.279.14.1100.
  • Wenthur CJ. Classics in chemical neuroscience: methylphenidate. ACS Chem Neurosci. 2016;7(8):1030–1040. doi: 10.1021/acschemneuro.6b00199.
  • Spiller HA, Hays HL, Aleguas A. Overdose of drugs for attention-deficit hyperactivity disorder: clinical presentation, mechanisms of toxicity, and management. CNS Drugs. 2013;27(7):531–543. doi: 10.1007/s40263-013-0084-8.
  • Poulton AS, Bui Q, Melzer E, et al. Stimulant medication effects on growth and bone age in children with attention-deficit/hyperactivity disorder: a prospective cohort study. Int Clin Psychopharmacol. 2016;31(2):93–99. doi: 10.1097/YIC.0000000000000109.
  • Lu CK, Kuang TM, Chou JCK. Methylphenidate (ritalin)-associated cataract and glaucoma. J Chin Med Assoc. 2006;69(12):589–590. doi: 10.1016/S1726-4901(09)70335-1.
  • Soyer J, Jean-Louis J, Ospina LH, et al. Visual disorders with psychostimulants: a paediatric case report. Paediatr Child Health. 2019;24(3):153–155. doi: 10.1093/pch/pxz012.
  • Mancera N, Wadia HP. Corneal edema associated with systemic dopaminergic agents. Cornea. 2019;38(8):1040–1042. doi: 10.1097/ICO.0000000000001941.
  • Bingöl‑Kızıltunç P, Yürümez E, Atilla H. Does methylphenidate treatment affect functional and structural ocular parameters in patients with attention deficit hyperactivity disorder? – A prospective, one year follow‑up study. Indian J Ophthalmol. 2022;70(5):1664–1668. doi: 10.4103/ijo.IJO_2966_21.
  • LeBlanc-Duchin D, Taukulis HK. Behavioral reactivity to a noradrenergic challenge after chronic oral methylphenidate (ritalin®) in rats. Pharmacol Biochem Behav. 2004;79(4):641–649. doi: 10.1016/j.pbb.2004.09.021.
  • Grueb M, Wallenfels-Thilo B, Denk O, et al. Monoamine receptors in human corneal epithelium and endothelium. Acta Ophthalmol Scand. 2006;84(1):110–115. doi: 10.1111/j.1600-0420.2005.00551.x.
  • Cavallotti C, Pescosolido N, Pescosolido V, et al. Determination of dopamine D1 receptors in the human uveo scleral tissue by light microscope autoradiography. Int Ophthalmol. 1999;23(3):171–179. doi: 10.1023/A:1010611419602.
  • Crosson CE, Beuerman RW, Klyce SD. Dopamine modulation of active ion transport in rabbit corneal epithelium. Investig Ophthalmol Vis Sci. 1984;25(11):1240–1245.
  • Gozil M, Take G, Bahcelioglu M, et al. Dose-dependent ultrastructural changes in rat cornea after oral methylphenidate administration. Saudi Med J. 2008;29:498–502.
  • Attention Deficit Hyperactivity Disorder. Therapeutic guidelines limited. 2016. http://online.tg.org.au.
  • The Royal Australian College of General Practitioners. The pharmaceutical society of Australia. Australasian society for clinical and experimental pharmacologists and toxicologists. Methylphenidate. Australian medicines handbook. Rundle Mall, SA: Austral; 2021.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.